1. Home
  2. DDD vs ASMB Comparison

DDD vs ASMB Comparison

Compare DDD & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 3D Systems Corporation

DDD

3D Systems Corporation

HOLD

Current Price

$2.27

Market Cap

373.9M

Sector

Technology

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$27.34

Market Cap

414.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDD
ASMB
Founded
1986
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
373.9M
414.7M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
DDD
ASMB
Price
$2.27
$27.34
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$4.75
$43.40
AVG Volume (30 Days)
3.9M
98.0K
Earning Date
03-25-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$391,651,000.00
$37,191,000.00
Revenue This Year
N/A
$33.33
Revenue Next Year
$1.31
N/A
P/E Ratio
$21.77
N/A
Revenue Growth
N/A
31.30
52 Week Low
$1.32
$7.75
52 Week High
$4.85
$39.71

Technical Indicators

Market Signals
Indicator
DDD
ASMB
Relative Strength Index (RSI) 49.33 44.62
Support Level $1.97 $25.14
Resistance Level $2.35 $27.48
Average True Range (ATR) 0.17 1.71
MACD -0.04 0.20
Stochastic Oscillator 30.98 45.45

Price Performance

Historical Comparison
DDD
ASMB

About DDD 3D Systems Corporation

3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: